K252296 is an FDA 510(k) clearance for the OncoPatch. This device is classified as a Source, Brachytherapy, Radionuclide (Class II - Special Controls, product code KXK).
Submitted by Oncopatch, Inc. (Aurora, US). The FDA issued a Cleared decision on December 5, 2025, 135 days after receiving the submission on July 23, 2025.
This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.
| 510(k) Number | K252296 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | July 23, 2025 |
| Decision Date | December 05, 2025 |
| Days to Decision | 135 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | KXK - Source, Brachytherapy, Radionuclide |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 892.5730 |